These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


274 related items for PubMed ID: 28146070

  • 1. Decreased Expression of Vitamin D Receptor Affects an Immune Response in Primary Biliary Cholangitis via the VDR-miRNA155-SOCS1 Pathway.
    Kempinska-Podhorodecka A, Milkiewicz M, Wasik U, Ligocka J, Zawadzki M, Krawczyk M, Milkiewicz P.
    Int J Mol Sci; 2017 Jan 29; 18(2):. PubMed ID: 28146070
    [Abstract] [Full Text] [Related]

  • 2. Liver Expression of Sulphotransferase 2A1 Enzyme Is Impaired in Patients with Primary Sclerosing Cholangitis: Lack of the Response to Enhanced Expression of PXR.
    Wunsch E, Klak M, Wasik U, Milkiewicz M, Blatkiewicz M, Urasinska E, Barbier O, Bielicki D, Bogdanos DP, Elias E, Milkiewicz P.
    J Immunol Res; 2015 Jan 29; 2015():571353. PubMed ID: 26504856
    [Abstract] [Full Text] [Related]

  • 3. Ursodeoxycholic acid influences the expression of p27kip1 but not FoxO1 in patients with non-cirrhotic primary biliary cirrhosis.
    Milkiewicz M, Kopycińska J, Kempińska-Podhorodecka A, Haas T, Bogdanos DP, Elias E, Milkiewicz P.
    J Immunol Res; 2014 Jan 29; 2014():921285. PubMed ID: 24741631
    [Abstract] [Full Text] [Related]

  • 4. miR-425 regulates inflammatory cytokine production in CD4+ T cells via N-Ras upregulation in primary biliary cholangitis.
    Nakagawa R, Muroyama R, Saeki C, Goto K, Kaise Y, Koike K, Nakano M, Matsubara Y, Takano K, Ito S, Saruta M, Kato N, Zeniya M.
    J Hepatol; 2017 Jun 29; 66(6):1223-1230. PubMed ID: 28192189
    [Abstract] [Full Text] [Related]

  • 5. Activation of FoxO3a/Bim axis in patients with Primary Biliary Cirrhosis.
    Kopycinska J, Kempińska-Podhorodecka A, Haas T, Elias E, DePinho RA, Paik J, Milkiewicz P, Milkiewicz M.
    Liver Int; 2013 Feb 29; 33(2):231-8. PubMed ID: 23295054
    [Abstract] [Full Text] [Related]

  • 6. Increased sensitivity of Treg cells from patients with PBC to low dose IL-12 drives their differentiation into IFN-γ secreting cells.
    Liaskou E, Patel SR, Webb G, Bagkou Dimakou D, Akiror S, Krishna M, Mells G, Jones DE, Bowman SJ, Barone F, Fisher BA, Hirschfield GM.
    J Autoimmun; 2018 Nov 29; 94():143-155. PubMed ID: 30119881
    [Abstract] [Full Text] [Related]

  • 7. Hepatic Stem/Progenitor Cell Activation Differs between Primary Sclerosing and Primary Biliary Cholangitis.
    Carpino G, Cardinale V, Folseraas T, Overi D, Floreani A, Franchitto A, Onori P, Cazzagon N, Berloco PB, Karlsen TH, Alvaro D, Gaudio E.
    Am J Pathol; 2018 Mar 29; 188(3):627-639. PubMed ID: 29248458
    [Abstract] [Full Text] [Related]

  • 8. Alterations in tight junctions differ between primary biliary cirrhosis and primary sclerosing cholangitis.
    Sakisaka S, Kawaguchi T, Taniguchi E, Hanada S, Sasatomi K, Koga H, Harada M, Kimura R, Sata M, Sawada N, Mori M, Todo S, Kurohiji T.
    Hepatology; 2001 Jun 29; 33(6):1460-8. PubMed ID: 11391535
    [Abstract] [Full Text] [Related]

  • 9. Oncomir MicroRNA-346 Is Upregulated in Colons of Patients With Primary Sclerosing Cholangitis.
    Kempinska-Podhorodecka A, Blatkiewicz M, Wunsch E, Krupa L, Gutkowski K, Milkiewicz P, Milkiewicz M.
    Clin Transl Gastroenterol; 2020 Jan 29; 11(1):e00112. PubMed ID: 31972611
    [Abstract] [Full Text] [Related]

  • 10. ApaI polymorphism of vitamin D receptor affects health-related quality of life in patients with primary sclerosing cholangitis.
    Kempinska-Podhorodecka A, Milkiewicz M, Jabłonski D, Milkiewicz P, Wunsch E.
    PLoS One; 2017 Jan 29; 12(4):e0176264. PubMed ID: 28426778
    [Abstract] [Full Text] [Related]

  • 11. A pilot study exploring the role of glucocorticoid receptor variants in primary biliary cirrhosis and primary sclerosing cholangitis.
    ter Borg PC, Hagendorf A, van Buuren HR, Koper JW, Lamberts SW.
    Neth J Med; 2004 Oct 29; 62(9):326-31. PubMed ID: 15635817
    [Abstract] [Full Text] [Related]

  • 12. Decreased expression of vitamin D receptor may contribute to the hyperimmune status of patients with acquired aplastic anemia.
    Yu W, Ge M, Lu S, Shi J, Feng S, Li X, Zhang J, Wang M, Huang J, Shao Y, Huang Z, Zhang J, Nie N, Zheng Y.
    Eur J Haematol; 2016 May 29; 96(5):507-16. PubMed ID: 26152509
    [Abstract] [Full Text] [Related]

  • 13. Modulation of Mismatch Repair and the SOCS1/p53 Axis by microRNA-155 in the Colon of Patients with Primary Sclerosing Cholangitis.
    Adamowicz M, Stukan I, Milkiewicz P, Bialek A, Milkiewicz M, Kempinska-Podhorodecka A.
    Int J Mol Sci; 2022 Apr 28; 23(9):. PubMed ID: 35563301
    [Abstract] [Full Text] [Related]

  • 14. Immunolocalization of putative human liver progenitor cells in livers from patients with end-stage primary biliary cirrhosis and sclerosing cholangitis using the monoclonal antibody OV-6.
    Crosby HA, Hubscher S, Fabris L, Joplin R, Sell S, Kelly D, Strain AJ.
    Am J Pathol; 1998 Mar 28; 152(3):771-9. PubMed ID: 9502419
    [Abstract] [Full Text] [Related]

  • 15. Enhanced expression of miR-21 and miR-150 is a feature of anti-mitochondrial antibody-negative primary biliary cholangitis.
    Wasik U, Kempinska-Podhorodecka A, Bogdanos DP, Milkiewicz P, Milkiewicz M.
    Mol Med; 2020 Jan 16; 26(1):8. PubMed ID: 31948396
    [Abstract] [Full Text] [Related]

  • 16. Apoptosis of biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis.
    Tinmouth J, Lee M, Wanless IR, Tsui FW, Inman R, Heathcote EJ.
    Liver; 2002 Jun 16; 22(3):228-34. PubMed ID: 12100573
    [Abstract] [Full Text] [Related]

  • 17. [Cholestatic liver diseases].
    Grimm D, Thimme R.
    Ther Umsch; 2011 Apr 16; 68(4):195-9. PubMed ID: 21452140
    [Abstract] [Full Text] [Related]

  • 18. Impact of Microbes on the Pathogenesis of Primary Biliary Cirrhosis (PBC) and Primary Sclerosing Cholangitis (PSC).
    Mattner J.
    Int J Mol Sci; 2016 Nov 09; 17(11):. PubMed ID: 27834858
    [Abstract] [Full Text] [Related]

  • 19. Naturally-occurring regulatory T cells are increased in inflamed portal tracts with cholangiopathy in primary biliary cirrhosis.
    Sasaki M, Ikeda H, Sawada S, Sato Y, Nakanuma Y.
    J Clin Pathol; 2007 Oct 09; 60(10):1102-7. PubMed ID: 17158635
    [Abstract] [Full Text] [Related]

  • 20. Decreased in vitro production of tumor necrosis factor in primary biliary cirrhosis patients.
    Broomé U, Eriksson LS, Sundin U, Sundqvist KG.
    Scand J Gastroenterol; 1992 Oct 09; 27(2):124-8. PubMed ID: 1561525
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.